Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, trips or professional assistance with a real medical doctor. We aren't docs. Always confer with your doctor about Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease Clinical research trials and Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease health trials happen in many of cities across the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the effectualness of new does drugs. The intention of the studies / projects is to figure out particular human healthcare questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to detect cures for all forms of circumstances, like Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease. Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment options before they are available to the general public. Most times the subjects get treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease clinical trial. Subjects frequently get the best healthcare possible for their Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease condition. Hazards are a reality, however, and could include more or frequent mD visits, health risks (possibly life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with exacting guidelines to protect clinical trials patients.

Home > "E" Clinical Trials Conditions > Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease

Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease



Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease

For Condition: Dementia, Alzheimer Type
Status: Completed
Sponsor(s): Johnson & Johnson Pharmaceutical Research and Development, L.L.C. ,
Synopsis: The purpose of this study is to compare the effectiveness and safety of risperidone versus placebo in patients that have been diagnosed with psychosis of Alzheimer's Disease
Details:
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 55 Years/
Genders: Both
Protocol Entry Criteria: - Subjects have a diagnosis of dementia of the Alzheimer's type (DSM-IV 290.xx) with or without a vascular component, provided the vascular component is not the primary source of dementia. - Subjects have a diagnosis of psychosis of AD as defined by the modified diagnostic criteria from Jeste & Finkel (see Addendum 1). - Subjects have a BEHAVE-AD psychotic score of >2 on any item in the psychotic cluster at screening. - Subjects have a score ranging from 5 to 23 on the MMSE. - All subjects enrolled would be deemed to be in need of treatment with an atypical antipsychotic. - Prior to screening, subjects must have resided in a unit of a nursing home or other long-term care facility for at least two weeks and will remain institutionalized in the same unit for at least the next 9 weeks. - Subjects should be ambulatory, walk with assistance or be able to use a wheelchair independently.
Total Enrollment: 467

Location and Contact Information:

Clinical Research Services @ Tennessee Christian Medical Center
Madison,  Tennessee,  37115
United States
 

Behavioral Medical Research of Staten Island, P.C.
Staten Island,  New York,  10305
United States
 

First Dynamic Health Care Services
Waco,  Texas,  76708
United States
 

Suzanne Gazda, MD
San Antonio,  Texas,  78225
United States
 

Vince & Associates Clinical Research
Overland Park,  Kansas,  66211
United States
 

Upstate Clinical research, LLC
Albany,  New York,  12205
United States
 

Axiom Clinical Research of Florida
Tampa,  Florida,  33609-4052
United States
 

Carillon House
Lubbock,  Texas,  79416
United States
 

Geriatric Associates of America
Baytown,  Texas,  77520
United States
 

Valley Medical Center
Centerville,  Ohio,  45459
United States
 

Abigail Rayner
Madisonville,  Kentucky,  42431
United States
 

Grayline Clinical Drug Trials
Wichita Falls,  Texas,  76309
United States
 

Mission Lodge
San Gabriel,  California,  91776
United States
 

Berma Research Group
Hialeah,  Florida,  33016
United States
 

Caprock Clinical Research
Lubbock,  Texas,  79410
United States
 

OSF Center for Senior Health
Peoria,  Illinois,  61603-3089
United States
 

Tuscaloosa VA Medical Center
Tuscallosa,  Alabama,  35405
United States
 

First Dynamic Health Care Services
Waco,  Texas,  76708
United States
 

FutureSearch Trials
Austin,  Texas,  78756
United States
 

North East Ohio Health Services
Beachwood,  Ohio,  44122
United States
 

Centers for Behavioral Health
Baltimore,  Maryland,  21208
United States
 

First Dynamic Health Care Services
Waco,  Texas,  76708
United States
 

Clinical Pharmaceutical Trials, Inc.
Tulsa,  Oklahoma,  74104
United States
 

Gulf Coast Education and Research Center
Port Charlotte,  Florida,  33952
United States
 

University of Hawaii Geriatric Education and Research
Honolulu,  Hawaii,  96817
United States
 

University of South Dakota
Sioux Falls,  South Dakota,  57105
United States
 

Neurobehavioral Research Inc.
Lawrence,  New York,  11559
United States
 

Agewell
Indianapolis,  Indiana,  46260
United States
 

Cranmer Associates Medical Group
Oklahoma City,  Oklahoma,  73112
United States
 

University of Virginia -- Dept. of Neurology
Charlottesville,  Virginia,  22903
United States
 

South Texas Medical Research Association
San Antonio,  Texas,  78238
United States
 

MedWise Center
Manchester,  New Jersey,  08733
United States
 

Jewish Home and Hospital for the Aged
New York City,  New York,  10025
United States
 

Hawaii Clinical Research Center
Honolulu,  Hawaii,  96826
United States
 

Pacific Research Network
San Diego,  California,  92103
United States
 

Center for Geriatric & Adult Psychiatry
Hamden,  Connecticut,  06518
United States
 

Comprehensive Neuroscience Inc.
White Plains,  New York,  10605
United States
 

Segal Institute for Clinical Research
Miami,  Florida,  33161
United States
 

Olean General Hospital West
Olean,  New York,  14760
United States
 

IPS Research Copy
Oklahoma City,  Oklahoma,  73103
United States
 

Long Term Care Psychiatry, Inc.
Providence,  Rhode Island,  02906
United States
 

Alzheimer Research and Clinical Programs -- Medical University of South Carolina
Charleston,  South Carolina,  29406-6076`
United States
 

VA Medical Center-Coatesville
Coatesville,  Pennsylvania,  19320-2096
United States
 

UT Southwestern Medical Center
Dallas,  Texas,  75235-9070
United States
 

Centers for Behavioral Health
Rockville,  Maryland,  20850
United States
 

Memory Disorder Center
Pompano Beach,  Florida,  33064
United States
 

Psychiatric Consultants, PC
Nashville,  Tennessee,  37203
United States
 


Additional Information:
Study ID Numbers:
  RIS-USA-232; 
Study Start Date: December 2000
Record last reviewed: January 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00034762

Other Dementia, Alzheimer Type Studies:
1. Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease

Related Studies:

Other Dementia, Alzheimer Type Clinical Trials
Other Texas Clinical Trials
Other San Antonio Clinical Trials

Efficacy and Safety of Risperidone versus Placebo in patients with Psychosis of Alzheimer's Disease

Modify your Search

  Other Dementia, Alzheimer Type Clinical Trials
  Other Texas Clinical Trials
  Other San Antonio Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103